International Collaborative for Drug Stability Testing
A BSAC initiative
Directory
The Directory is open to all organisations or individuals engaged or with an interest in drug stability testing. We hope that over time the directory will enable individuals and organisations to identify who else is working in the field, to contact each other to share information, expertise and where appropriate form collaborative working relationships.
British Society for Antimicrobial Chemotherapy
Name of research group
UK OPAT Initiative
Country
United Kingdom
Public or Privately funded
Public
Currently engaged in drug stability testing?
Yes
Interested in collaborative working?
Yes
Currently working collaboratively on stability testing?
Yes
Publish results open access?
Yes
Details about the research group
The BSAC Drug Stability Testing Programme exists to provide evidence on the stability of agents and devices used in infection management practice, particularly those used in outpatient parenteral antimicrobial (OPAT) therapy services. The programme will provide an expanding repository of open access data on drug and device stability compliant with UK NHS standards as provided by the yellow Covered Document. For the first time healthcare professionals will be able to reference open access stability data reports to aid decision making, inform practice and offer opportunities to improve patient safety and patient outcomes, especially within the OPAT arena. The programme objectives are central to the charitable objective of the British Society for Antimicrobial Chemotherapy which is “To support the acquisition and dissemination of knowledge in the field of antimicrobial chemotherapy”
Contact details
Conor Jamieson, Chair, BSAC Drug Stability Testing Programme & Antimicrobial Pharmacist
+44 121 236 1988